Therapeutic utility of clinical & laboratory markers in chronic spontaneous urticaria - a narrative review. (PubMed, Expert Rev Clin Pharmacol) - Oct 23, 2026 - "There is a need to design therapeutic studies that inculcate biomarkers. Novel agents like dupilumab, BTK inhibitors and JAK inhibitors have yet not been studied based on biomarkers."
Journal • Review • Cardiovascular • Chronic Spontaneous Urticaria • Dermatology • Immunology • Urticaria • CRP
|
|
Aishwarya Muddebihal; Kabir Sardana; Mohammad Adil
|